CEVAC VITAPEST L
CEVAC VITAPEST L
Authorised
- Newcastle disease virus, strain PHY.LMV.42, Live
Product identification
Medicine name:
CEVAC VITAPEST L
Active substance:
- Newcastle disease virus, strain PHY.LMV.42, Live
Target species:
-
Chicken
Route of administration:
-
Oculonasal use
-
Nebulisation use
Product details
Active substance and strength:
-
Newcastle disease virus, strain PHY.LMV.42, Live5.50/log 10 50% embryo infective dose0.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate for oculonasal suspension
Withdrawal period by route of administration:
-
Oculonasal use
- Chicken
-
Meat and offal0day
-
Eggs0day
-
-
Nebulisation use
- Chicken
-
Meat and offal0day
-
Eggs0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Romania
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
Responsible authority:
- Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
- 120239
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 3/08/2023
How useful was this page?:
